NCNA

NuCana plc - American Depositary Shares (NCNA)

About NuCana plc - American Depositary Shares (NCNA)

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

Details

Daily high

$3.64

Daily low

$3.46

Price at open

$3.50

52 Week High

$330.00

52 Week Low

$2.78

Market cap

15.1M

Dividend yield

0.00%

Volume

41,238

Avg. volume

61,050

P/E ratio

-.02

NuCana plc - American Depositary Shares News